Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia.
Leuk Res
; 121: 106923, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35933910
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Chronic-Phase
/
Drug Tapering
Limits:
Humans
Language:
En
Journal:
Leuk Res
Year:
2022
Document type:
Article